ChairmanMr. Norris is a broadly successful C-level executive, entrepreneur and innovator with noted accomplishments spanning both the private and public sectors of science, medicine, information-technology, law, and regulatory affairs / enforcement . John Norris was previously the COO and Deputy Commissioner of the United States Food and Drug Administration (FDA). He has served as a key advisor to top pharmaceutical executives, including those at Merck, Pfizer, Glaxo, and Johnson & Johnson.
Mr. Norris has served as Co-Founder of seven companies including Coprindm, now DecisionView, a Granite and Adobe-Ventures backed company. He was a board member, Corporate EVP and Worldwide Managing Director of Life Sciences at Hill and Knowlton, a leading marketing and management consulting firm. He also served on the boards of Horus Therapeutics, Inc., acquired by Johnson & Johnson in 1998, and Summit Technology, a laser eye surgery equipment manufacturer acquired for $1 billion by LCA-Vision, Inc. in 1997.
Mr. Norris has served as the Deputy Commissioner and COO of the FDA. He was a member of President Reagan’s Chernobyl Commission and a member of the Heath & Human Services Secretary’s Medicare Commission. He also has served as a member of or advisor to key quasi-government boards, including the Institute of Medicine in Washington and the International Council for Global Health Progress.
Mr. Norris, as an adjunct lecturer at the Harvard School of Public Health has taught and lectured in all areas of his subject matter expertise including regulation, policy and management, and reimbursement for the past 15 years. Much of his work in academia has been associated with the late Dr. William Curran, the “Dean” of American Health Law and Public Policy, and Harvard’s Francis Glessner Lee Professor of Law and Medicine, and Former FDA Commissioner, Dr. Frank Young, the “Dean” of FDA reform.
Mr. Norris has chaired, sponsored or keynoted over 100 national or international conferences and has given over 100 national or international interviews on matters concerning his primary areas of expertise. He has collaborated with a large number of industry luminaries such as Dr. Richard Dick of the Institute of Medicine, Mr. Al Niemeth of Cornell University, Dr. Yin Yang of Horus, and Dr. Elmer Gabrieli of CBM. He has extensive participation in the International Conference on Harmonization, the prestigious pharmaceutical standards setting board.
Mr. Norris has received numerous awards including the American Society of Law, Medicine, and Ethics’ Life Membership Award, and a federal fellowship for J.D., M.B.A., and healthcare policy and management studies at Cornell. He has served as Founding Editor-in-Chief of the American Journal of Law and Medicine. Mr. Norris holds an undergraduate degree in Economics, with minors in Chemical Engineering and Political Science, from The University of Rochester, a J.D. and M.B.A. from Cornell University.